Year-end Sale % OFF 
Abstract
Although IL17A plays a protective role at the mucosal surface, when IL17A signaling becomes dysregulated, a pathological response is locally induced. At the early stages of Mycobacterium tuberculosis (M.tb) infection, IL17A contributes to granuloma formation and pathogen containment. In contrast, during disease progression, a dysregulated IL17A hyperinflammatory response drives tissue destruction through enhanced neutrophil recruitment. Cumulative research has implicated the PI3-Kinase pathways as one of the most relevant in the pathophysiology of inflammation. Evidence shows that IL-17A secretion and the expansion of the Th17 population is dependant in PI3-Kinase signaling, with the p110δ and p110γ isoforms playing a prominent role. The p110γ isoform promotes disease progression through dampening of the Th17 response, preventing pathogen clearance and containment. The p110γ gene, PIK3CG is downregulated in TB patients during late-stage disease when compared to healthy controls, demonstrating an important modulatory role for this isoform during TB. Conversely, the p110δ isoform induces IL-17A release from pulmonary γδ T-cells, committed Th17 cells and promotes neutrophil recruitment to the lung. Inhibiting this isoform not only suppresses IL-17A secretion from Th17 cells, but it also inhibits cytokine production from multiple T-helper cell types. Since increased IL-17A levels are observed to be localized in the lung compartments (BAL and lymphocytes) in comparison to circulating levels, an inhalable PI3Kδ inhibitor, which is currently utilized for inflammatory airway diseases characterized by IL-17A over-secretion, may be a therapeutic option for active TB disease.
Highlights
IL-17A is mostly active at mucosal sites and plays a primarily protective role at the lung surface through bridging the gap between the innate and adaptive immune responses [1, 2]
IL-17A contributes to the formation of a mature granuloma [10, 11] which constrains the multiplication of Mycobacterium tuberculosis (M.tb) clinical isolates and plays a protective role [12].This is observed during infection with hypervirulent M.tb strains
Even though IL-17 production may be required for early granuloma formation, it’s chronic or exacerbated secretion may be detrimental as it promotes neutrophil accumulation which compromises the generation of a stable mononuclear granuloma
Summary
IL-17A is mostly active at mucosal sites and plays a primarily protective role at the lung surface through bridging the gap between the innate and adaptive immune responses [1, 2]. PI3Kδ and PI3Kγ are expressed predominantly in leukocytes and have been studied intensively in the context of immune-mediated diseases Both isoforms are required in some cellular responses such as the generation of ROS by neutrophils and the degranulation of mast cells, which suggests that the contribution of each isoform is coordinated at different stages [31,32,33]. In resistant hosts, this results in granuloma formation and effective containment of the bacilli. Development, survival and differentiation of Th1, Th2, and Th17 cell subsets has been demonstrated
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
